BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6095828)

  • 1. Susceptibility of platelet alpha-actinin to a Ca2+-activated neutral protease.
    Gache Y; Landon F; Touitou H; Olomucki A
    Biochem Biophys Res Commun; 1984 Nov; 124(3):877-81. PubMed ID: 6095828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of two proteins (actin-binding protein and P235) that are hydrolyzed by endogenous Ca2+-dependent protease during platelet aggregation.
    Fox JE; Goll DE; Reynolds CC; Phillips DR
    J Biol Chem; 1985 Jan; 260(2):1060-6. PubMed ID: 2981831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphism of alpha-actinin from human blood platelets. Homodimeric and heterodimeric forms.
    Gache Y; Landon F; Olomucki A
    Eur J Biochem; 1984 May; 141(1):57-61. PubMed ID: 6723664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and physico-chemical properties of blood platelet alpha-actinin.
    Landon F; Olomucki A
    Biochim Biophys Acta; 1983 Jan; 742(1):129-34. PubMed ID: 6824676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium-dependent proteolysis occurs during platelet aggregation.
    Fox JE; Reynolds CC; Phillips DR
    J Biol Chem; 1983 Aug; 258(16):9973-81. PubMed ID: 6309792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. alpha-Actinin and membrane glycoprotein IIIa are different proteins in human blood platelets.
    Langer BG; Leung LL; Gonnella PA; Nachmias VT; Nachman RL; Pepe FA
    Proc Natl Acad Sci U S A; 1982 Jan; 79(2):432-5. PubMed ID: 6176993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and characterization of a calpain activator from human platelets.
    Shiba E; Ariyoshi H; Yano Y; Kawasaki T; Sakon M; Kambayashi J; Mori T
    Biochem Biophys Res Commun; 1992 Jan; 182(2):461-5. PubMed ID: 1734861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific cleavage of calmodulin-binding proteins by low Ca2+-requiring form of Ca2+-activated neutral protease in human platelets.
    Kosaki G; Tsujinaka T; Kambayashi J; Morimoto K; Yamamoto K; Yamagami K; Sobue K; Kakiuchi S
    Biochem Int; 1983 Jun; 6(6):767-75. PubMed ID: 6091657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of the cytoskeletal protein alpha-actinin as a platelet thrombospondin-binding protein.
    Dubernard V; Faucher D; Launay JM; Legrand C
    FEBS Lett; 1995 May; 364(2):109-14. PubMed ID: 7750553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the Ca2+-activated neutral proteinase of rabbit skeletal muscle. I. The characterization of the 80 K and the 30 K subunits.
    Tsuji S; Imahori K
    J Biochem; 1981 Jul; 90(1):233-40. PubMed ID: 6270079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification and characterization of a low calcium requiring form of Ca2+-activated neutral protease from human platelets.
    Tsujinaka T; Shiba E; Kambayashi J; Kosaki G
    Biochem Int; 1983 Jan; 6(1):71-80. PubMed ID: 6089805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limited proteolysis of bovine lens alpha-crystallin by calpain, a Ca2+-dependent cysteine proteinase, isolated from the same tissue.
    Yoshida H; Murachi T; Tsukahara I
    Biochim Biophys Acta; 1984 Apr; 798(2):252-9. PubMed ID: 6324878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification and characterization of platelet actin, actin-binding protein, and alpha-actinin.
    Schaier SR
    Methods Enzymol; 1992; 215():58-77. PubMed ID: 1435344
    [No Abstract]   [Full Text] [Related]  

  • 14. Properties of two isoforms of human blood platelet alpha-actinin.
    Landon F; Gache Y; Touitou H; Olomucki A
    Eur J Biochem; 1985 Dec; 153(2):231-7. PubMed ID: 2934249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stringent requirement for Ca2+ in the removal of Z-lines and alpha-actinin from isolated myofibrils by Ca2+-activated neutral proteinase.
    Reddy MK; Rabinowitz M; Zak R
    Biochem J; 1983 Mar; 209(3):635-41. PubMed ID: 6307260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Micromolar Ca2+ requiring protease from human platelets: purification, partial characterization and effect on the cytoskeletal proteins.
    Malik MN; Ramaswamy S; Tuzio H; Shiekh AM; Fenko MD; Wisniewski HM; Howard RG
    Life Sci; 1987 Feb; 40(6):593-604. PubMed ID: 3027489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ca-activated neutral protease and its inhibitors: in vitro effect on intact myofibrils.
    Sugita H; Ishiura S; Suzuki K; Imahori K
    Muscle Nerve; 1980; 3(4):335-9. PubMed ID: 6251364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cleavage of fibrinogen by human platelet calcium-activated protease.
    Kunicki TJ; Mosesson MW; Pidard D
    Thromb Res; 1984 Jul; 35(2):169-82. PubMed ID: 6089371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification of human platelet calcium-activated protease. Effect on platelet and endothelial function.
    Yoshida N; Weksler B; Nachman R
    J Biol Chem; 1983 Jun; 258(11):7168-74. PubMed ID: 6304081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversible interaction between Ca2+-activated neutral protease (CANP) and its endogenous inhibitor.
    Imajoh S; Suzuki K
    FEBS Lett; 1985 Jul; 187(1):47-50. PubMed ID: 2991009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.